Featuring Internationally Renowned Speakers From USA,
UK, France, Germany Italy, Australia Japan, Singapore,
Taiwan, Korea, China and India
~ John Siebert, CEO, Cydex
~ Alexandre Williams, MD, Asia- Pacific, Ethypharm
~ George Yeh, GM, TLC
~ John Staniforth, CSO, Vectura
~ Adam Watkinson, CSO, Acrux
~ Jochen Meister, Strategic Alliance Manager, Novartis
~ Ravi Kiron, Executive Director, Alza Corporation, USA
~ Mark Parry-Billings, RND Director, Psivida
~ Ramani Aiyer, Senior VP, Nicholas Piramal
~ Steve Ellul, Director, Business Development, Eurand
~ Paul Heng, Professor,NUS
~ Kim Bill,VP, Business Development, Debiopharm
~ Naoto Oku, Dean, University of Shizuoko
~ Akira Tsuji, Dean, Kanazawa University
~ Youngro Byun, Profesor,Seoul National University
~ Yi Yan Yang, Group Leader, IBN, A* Star
PLUS
A Post Conference Workshop on Optimizing Licensing Deals
in Asia, Europe & US led by Dr. Fintan Walton. A series
of interactive presentations/ discussions interspersed
with group working on negotiation and the valuation of
the hypothetical drug delivery pharmaceutical product,
through which delegates will have the opportunity to put
the approaches, methods and techniques introduced into
practice
For
more information, please contact Customer Service
hotline at +65 6514 3180 or email: register@ibcasia.com.sg,
Download PDF programme
HERE.
Mx Asia
is aimed at those interested in the effective
development, launch, manufacture and use of medical
devices and forming strategic partnerships with medical
devices companies, service & solution providers &
suppliers. This event will focus on exploring
opportunities and addressing needs of innovators,
startup companies & multinational companies operating in
Asia as well as researchers and clinicians interested in
the translation of their research into products.
Key benefits of attending
Ø Meet
potential business partners, collaborators, licensees and investors to explore
effective supplier
partnerships, discover solutions to grow your business,
opportunities for technology licensing, collaboration
and joint ventures
Ø Learn
from industry leaders about the trends in the industry from a technology,
customer-focused and
regulatory perspective
Ø Network
with innovators, clinicians, regulators, representatives
from large corporations, investors and service &
solution providers at the many networking opportunities
and take advantage of the facilities for one -to-one
meeting available at the conference venue
Ø Evaluate
new technologies and products presented during the
conference & in the exhibition
Ø Get
questions answered by the experts on a every aspect of
bringing a product to market: clinical trials
and validation, IP protection, regulatory and quality
standards, reimbursement, pricing and managing partnerships.
Who Should Attend
Ø Global, regional and local medical devices companies
Ø Medical devices distributors/ agents/resellers, vendors,
suppliers & fabricators, OEM manufacturers
Ø Consultants, advisors and service & solution providers
to the industry
Ø
Researchers (bio-scientist, bio-engineers,
technologists)
Ø Surgeons and medical practitioners specialists in the
fields of cardiology, urology, orthopedics,
neurology, ophthalmology, metabolic disorders and
biomedical engineering
Ø
Government officials, policy-makers and regulators
Ø Entrepreneurs & Investors
Speakers to date:
Ø
Ralph Ives, Association of Advanced Medical Technologies
(Advamed), USA
Ø
Patrick Yi, Group CEO and President, Surgilance,
Singapore
Ø
Philip Greenfield , Publisher, CLINICA , World Medical
Technology News, UK
Ø
Fredrik Nyberg, Managing Partner, Biomedical Strategy
Consultants Pte Ltd, Singapore
Ø
Clemens Mohr, Consultant, MT Promedt Consulting GmbH ,
Germany
Ø
Robert N Clark, M.S. RAC, President and Senior
Consultant, Medical Device Regulatory Advisors,
Inc., USA
Ø
Edwin Chan Shih-Yen, Ph.D., Head of Evidence-Based
Medicine and
Director of the Singapore Branch, Australasian Cochrane
Centre Clinical Trials & Epidemiology Research Unit,
Singapore
Ø David Ho, Director , Protection Division, Mindvault Sdn
Bhd, Malaysia
Ø Janet McNicholas , Ph.D., Partner, Mc Andrews, Held and
Mollay, USA
Ø Reenita Das, VP, Healthcare Asia Pacific, Frost and
Sullivan, Australia
Ø Senior representatives from multinational medical device
companies
Ø Senior representative from Association of Malaysian
Medical Industries (AMMI)
Ø Senior representative from Medical Devices Bureau,
Ministry of Health, Malaysia (invited)
Ø Senior representatives from multinational medical device
companies
PLUS .....
3 STRATEGIC Pre-conference Workshops- 18
& 19 July 2006
Ø
The EU and US market: An overview of regulatory hurdles
for medical device manufacturers (full day
workshop on 18 July 2006)
Ø Bringing
medical technologies to market (half day on 17 July
2006)
Ø Intellectual
property protection strategy for medical devices in a
competitive global market (half day on 19 July 2006)
For more information, please contact Customer Service
hotline at +65 6514 3180 or
email:
register@ibcasia.com.sg,
Download PDF programme
HERE.
Ms Lynn Ng
Senior Marketing Manager
IBC Asia (S) Pte Ltd
No 1 Grange Road
#08-02 Orchard Building
Singapore 239693
Tel: +65 6835 5107
Fax: +65 6733 5087
Email: Lynn.Ng@ibcasia.com.sg
Other Related Events:
1)
BioPharma Opportunities China, 13-15 June, 2006,
Shanghai,
www.drugdisc.com/china
2) Drug Delivery & Licensing, 10-11 July, 2006,
Singapore
3) Pharma R&D Opportunities India, 10-12 October, 2006,
Mumbai, India,
www.drugdisc.com/india
4) Mx - Medical Devices for the Asian Market, 18-21
July, 2006, Kuala Lumpur, Malaysia
5) Private Healthcare Asia, 27-29 September, 2006,
Bangkok, Thailand
|